Friday, March 08, 2013 What Does the Dow Really

New Post Public Reply Private Reply Replies (2) Message Board
SaltyMutt
Friday, March 08, 2013

What Does the Dow Really Measure?

By Staff Report

The Dow Isn't Really At A Record High (And It Wouldn't Matter If It Were) ... Just a quick, cranky reminder: Despite what you may have read, the Dow Jones industrial average did not hit a new high today in any meaningful sense. After adjusting for inflation, the Dow was higher in 2000 than it is today. It was also higher in 2007. It would need to rise another 10 percent or so to hit an all time high in real (i.e., inflation-adjusted) terms. – Planet Money/NPR

Dominant Social Theme: The recovery is humming along.

Free-Market Analysis: As we mentioned in another article, today, the US is increasingly operating as a two-track society and simply observing the price of the Dow Jones Industrial Average does little to enlighten us about the real health of the US economy.

While NPR is not usually a bastion of financial literacy, this article posted at Planet Money is surprisingly candid about the realities of the DJIA's numbers and what they mean.

While a stock market average like this one is certainly representative of the progress of some of the US's largest companies, the figures do not necessarily imply that a solid recovery is underway. Here's more from the article.

When reporting on other numbers that change over time, it's routine to adjust for inflation. So when people talk about wages stagnating for American households, it means that, after you adjust for inflation, the median wage is roughly the same as it was 15 years ago. If you didn't adjust for inflation, you would say the median wage has risen by more than 40 percent over the past 15 years. But that would be a meaningless statement.

It's equally meaningless for the Dow. And even if the Dow did hit a real, inflation-adjusted, all-time high, it wouldn't mean much anyway. As our colleague Adam Davidson wrote last year:

The Dow average, drawn out to two decimal places, may seem like some perfectly scientific number, but it's far from it. A small committee selects 30 big companies — I.B.M., G.E., McDonald's, Disney and so forth — and then adds up the price of their stocks. Then the analysts divide it by the Dow Divisor, a misleadingly precise-seeming number formulated to account for things like dividends and splits that right now is, well, about 0.132129493. The resulting figure is repeated throughout the country.

And those are the least of the Dow's problems. More troubling is that it ignores the overall size of companies and pays attention to only their share prices. This causes all sorts of oddities. ExxonMobil, for example, divides its value into nearly five billion lower-cost shares, while Caterpillar has around 650 million more expensive ones. Therefore ExxonMobil, one of the largest companies in history, pulls less weight on the Dow than a company less than a fifth its size.

Looking at stock market averages and extrapolating significant conclusions from them may have been slightly more justifiable 50 or 75 years ago when monetary stimulation was less intense. But today, evidently and obviously, the stock market run-up in the US has been mainly the result of the various quantitative easing that the Fed has embarked upon.

As the NPR article points out, when these numbers are adjusted for inflation, they are still below the numbers that the markets achieved in 2007. But even this is misleading because the market achieved those numbers via additional intense Federal Reserve pump-priming.

In 2007, market averages were at an all time high and by 2008 the US economy – and the West's – were in ruins. This should be enough to do away with the idea that the stock market itself is an indicator of national prosperity. It is not.

The stock market is easily manipulated by money flows. When central banks generate large money flows via their printing presses, some of this money inevitably finds its way into the financial markets and pushes them up. The mainstream media then does its best – as instructed – to explain these averages are a sign of recovery.

In the 21st century, however, stock averages are more disconnected from underlying economic realities than ever before. In some sense, one could argue that the Dow currently measures the volume of financial manipulation rather than the underlying health of the economy.

Conclusion: Increasingly, one should look to other indicators to determine economic health, including overall GDP, the employment rate and even the number of people taking advantage of private charity and public assistance programs. Here, the news is certainly not good.



Latest Daily Bell Articles
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Iberostar's Grand Move: Opening in Zanzibar

Updated Category News Views 6

The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...

Continue Reading
Aurora Innovation Faces Legal Probe After Stock Plunge

Updated Category News Views 32

Aurora's Troubles Draw Legal Scrutiny Looks like Aurora Innovation’s in the hot seat again, and not in a good way. When you see Kessler Topaz Meltzer & Check, LLP throwing their name into the mix, you know it’s getting serious. This legal eagle firm is poking around, seeing if Aurora stepped over the line with investors after their latest stumble—a production delay...

Continue Reading
Auria, LSAS Team Up: Japan Space Frontier Beckons

Updated Category News Views 58

Pioneering Ventures in Japan's Space Race Watch out, folks—Auria and LSAS Tec have something cooking. One's a titan in space technology, and the other's a maestro in mission analysis. They're joining forces to tango in Japan's booming space market. If you're into the street-smart equity dance, this partnership ain't just chatter over coffee; it's a leap toward new...

Continue Reading
Exiger's CEO Honored for Military Support Excellence

Updated Category News Views 0

Recognizing Civilian and Military Leadership When you hear "recognition in the military sector," it isn't just a pat on the back. It's a whole parade of brass hats and high-flyers giving their nods. So, November 10th wasn't just any regular day—Brandon Daniels, CEO of Exiger, gets a shiny, prestigious Five-Star Award for his "extraordinary support" of our military...

Continue Reading
Texas Community Bancshares Adds a Special Dividend

Updated Category News Views 89

Nine cents is the whole message—for the moment Texas Community Bancshares has put a little extra cash on the table, declaring a regular quarterly dividend of $0.06 per common share and a special cash dividend of $0.03 per share. Together, holders get $0.09 per share, payable on or about December 15, 2026, provided they are shareholders of record when business closes on...

Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D

Updated Category News Views 23

Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...

Continue Reading
Vertiv's 800 VDC Push Gives AI Builders More Choices

Updated Category News Views 217

Electricity is becoming the awkward roommate inside every serious AI buildout, and Vertiv is trying to move it out of the rack before it eats the whole house. The company has expanded its 800 VDC offering beyond the PowerDirect 5000 rack product introduced in May 2026, laying out systems for the rack, the AI compute pod, and the full data hall. For investors following...

Continue Reading
Voranigo Follow-Up Deepens the Glioma Care Debate Today

Updated Category News Views 81

Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 20

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading
Bona's 2027 Floorcast Finds Wood and Trust Still Win

Updated Category News Views 147

Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...

Continue Reading

Top 5 Most Recently Viewed Articles

DoubleLine Income Solutions Fund Announces Monthly Distribution

Updated Category News Views 43

Back when the DoubleLine Income Solutions Fund made its rounds with a $0.11 per share distribution, traders were left scratching their heads over what it really meant for income stability. Sure, on paper it looked like a win—monthly distributions usually signal healthy cash flow—but the devil's in the details. The $0.11 Question: Solid Distribution or Just Smoke? That...

Continue Reading
Antiarrhythmic Drugs Market Growth and Future Projections

Updated Category News Views 115

Understanding the Future of the Antiarrhythmic Drugs Market The global antiarrhythmic drugs market is on a promising trajectory, with forecasts indicating a significant rise from USD 1.02 billion in 2023 to a remarkable USD 1.77 billion by 2032. This growth represents a compounded annual growth rate (CAGR) of 6.30% from 2024 to 2032. Increasing Demand Driven by Rising...

Continue Reading
Alvarez & Marsal Capital Partners Joins Forces with East Coast Power for Growth

Updated Category News Views 539

Alvarez & Marsal Capital Partners Forms Strategic Alliance Alvarez & Marsal Capital Partners has announced a pivotal strategic partnership with East Coast Power, marking an essential move to boost the development of electric utility services. This collaboration promises to provide the necessary investment aimed at accelerating East Coast Power's growth, with a clear focus...

Continue Reading
Sinclair Media Invites Applications for 2025 Diversity Scholarship

Updated Category News Views 126

Sinclair Announces Diversity Scholarship Program for Students Sinclair has exciting news — the company's annual Diversity Scholarship program is officially open for submissions for the upcoming academic year. This initiative has contributed nearly $400,000 to support students pursuing their education since it began in 2013. Empowering Diverse Voices in Broadcasting The...

Continue Reading
Traveling in Comfort: King's Hawaiian Unveils Softwear Line

Updated Category News Views 111

Experience Unmatched Comfort with King’s Hawaiian Softwear In an exciting new initiative, King’s Hawaiian invites travelers to embrace total comfort with their latest collection: the Softwear line. Designed to echo the signature fluffiness of the brand's beloved dinner rolls, these ultra-soft sweatshirts and sweatpants provide a perfect blend of comfort and style....

Continue Reading